Fig. 2From: Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trialsQuality assessment of included studies in this review a. Risk of bias graph; b. Risk of bias summaryBack to article page